Jin W. Park

CHA Fertility Center Seoul Station
Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 267 publications

Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].

Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].

Journal: Oral oncology

Published: September 04, 2026

Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].

Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].

Journal: Oral oncology

Published: June 19, 2026

Dual-transporter-targeted oral nanomicelles of semaglutide enable enhanced intestinal absorption and metabolic reprogramming in obesity and diabetes.

Dual-transporter-targeted oral nanomicelles of semaglutide enable enhanced intestinal absorption and metabolic reprogramming in obesity and diabetes.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 17, 2026

Anticancer Effects of Broccoli Sprout Extract and Sulforaphane Through ROS-Induced MAPK Pathway in Breast Cancer Cells and Xenografts.

Anticancer Effects of Broccoli Sprout Extract and Sulforaphane Through ROS-Induced MAPK Pathway in Breast Cancer Cells and Xenografts.

Journal: Antioxidants (Basel, Switzerland)

Published: March 20, 2026

Targeting ferroptosis in gefitinib-resistant HCC827 NSCLC cells using erastin.

Targeting ferroptosis in gefitinib-resistant HCC827 NSCLC cells using erastin.

Journal: American journal of cancer research

Published: March 14, 2026

Targeting the ROS-JNK/p38 Axis: Schisandrin A as a Novel Therapeutic Candidate for Esophageal Squamous Cell Carcinoma.

Targeting the ROS-JNK/p38 Axis: Schisandrin A as a Novel Therapeutic Candidate for Esophageal Squamous Cell Carcinoma.

Journal: Journal of microbiology and biotechnology

Published: March 13, 2026

Erastin-Induced Ferroptosis Overcomes Oxaliplatin Resistance in Colorectal Cancer Cells.

Erastin-Induced Ferroptosis Overcomes Oxaliplatin Resistance in Colorectal Cancer Cells.

Journal: Biomolecules & therapeutics

Published: February 11, 2026

Batch Effects in Tumor-Only Next-Generation Sequencing Panel Sequencing and Implications for Copy Number Variant Detection.

Batch Effects in Tumor-Only Next-Generation Sequencing Panel Sequencing and Implications for Copy Number Variant Detection.

Journal: The Journal of molecular diagnostics : JMD

Published: January 07, 2026

Synergistic Antitumor Activity of Combination Therapy with a MET TKI Vabametkib and a Third-Generation EGFR TKI Lazertinib in MET-Amplified EGFR-Mutant NSCLC.

Synergistic Antitumor Activity of Combination Therapy with a MET TKI Vabametkib and a Third-Generation EGFR TKI Lazertinib in MET-Amplified EGFR-Mutant NSCLC.

Journal: Cancer research and treatment

Published: December 23, 2025

Identification of Metabolites and Antioxidant Constituents from Pyrus ussuriensis.

Identification of Metabolites and Antioxidant Constituents from Pyrus ussuriensis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 05, 2025

Lorazepam and Survival in Asian Patients with Pancreatic Cancer: A Retrospective Cohort Study.

Lorazepam and Survival in Asian Patients with Pancreatic Cancer: A Retrospective Cohort Study.

Journal: Journal of gastrointestinal cancer

Published: November 30, 2025

Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery.

Ligand-directed oral lipidic nanoplatform enables sustained ferroptosis and immune reprogramming via multivalent transporter-mediated metronomic delivery.

Journal: Theranostics

Published: August 24, 2025

Showing 1-12 of 267

Last Updated: 09/26/2026